The optics of the vials didn't bother me either. O

The optics of the vials didn't bother me either. One small criticism I'd make of this media appearance is that when talking about Leronlimab in the context of medical treatment, don't call it a "product." That makes it sound like you have something you want to sell. Call it medicine or a drug. Save "product" for investor presentations.

All in all, the video was a nice beginning of what will hopefully be bigger and more widespread TV spots.

What really bothers me today isn't peeling labels but relentless selling. We can't use the noteholder excuse anymore...